Wedbush Upgrades Cross Country Healthcare to Outperform, Raises Price Target to $15

Benzinga Newsdesk www.benzinga.com Positive 92.8%

Neg 0% Neu 0% Pos 92.8%

Wedbush analyst Michael Piccolo upgrades Cross Country Healthcare (NASDAQ:CCRN) from Neutral to Outperform and raises the price target from $11 to $15.